Fabino Life Sciences (BOM:543444) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2024)

Fabino Life Sciences Capex-to-Operating-Cash-Flow Chart

Competitive Comparison of Fabino Life Sciences's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fabino Life Sciences's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Capex-to-Operating-Cash-Flow falls into.

Fabino Life Sciences Capex-to-Operating-Cash-Flow Calculation

Fabino Life Sciences's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Mar. 2024 is calculated as

Fabino Life Sciences's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Life Sciences  (BOM:543444) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

Fabino Life Sciences Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Fabino Life Sciences (BOM:543444) Business Description